4.5 Article

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants

期刊

JOURNAL OF MEDICAL GENETICS
卷 49, 期 11, 页码 721-726

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/jmedgenet-2012-101155

关键词

-

资金

  1. Methusalem excellence program of the Flemish Government
  2. Centre of Excellence grant by the Special Research Fund of the University of Antwerp
  3. Research Foundation Flanders (FWO)
  4. Agency for Innovation by Science and Technology Flanders (IWT)
  5. Interuniversity Attraction Poles program (IAP) of the Belgian Science Policy Office [P6/43]
  6. Belgian Parkinson Foundation
  7. Foundation for Alzheimer Research (SAO/FRMA)
  8. FWO
  9. AV of the IWT
  10. Grants-in-Aid for Scientific Research [23249049, 22129006] Funding Source: KAKEN

向作者/读者索取更多资源

Background Two recent studies identified a mutation (p.Asp620Asn) in the vacuolar protein sorting 35 gene as a cause for an autosomal dominant form of Parkinson disease. Although additional missense variants were described, their pathogenic role yet remains inconclusive. Methods and results We performed the largest multi-center study to ascertain the frequency and pathogenicity of the reported vacuolar protein sorting 35 gene variants in more than 15,000 individuals worldwide. p.Asp620Asn was detected in 5 familial and 2 sporadic PD cases and not in healthy controls, p.Leu774Met in 6 cases and 1 control, p.Gly51Ser in 3 cases and 2 controls. Overall analyses did not reveal any significant increased risk for p.Leu774Met and p.Gly51Ser in our cohort. Conclusions Our study apart from identifying the p. Asp620Asn variant in familial cases also identified it in idiopathic Parkinson disease cases, and thus provides genetic evidence for a role of p.Asp620Asn in Parkinson disease in different populations worldwide.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据